Serum concentrations of tumour necrosis factor-alpha (TNF-α) and soluble TNF-α receptor p55 in patients with hypothyroidism and hyperthyroidism before and after normalization of thyroid function

Clinical Endocrinology

Volumn 57, Issue 4, 2002, Pages 515-521

  Díez, Juan J ^a,c   Hernanz, Angel ^a   Medina, Sonia ^a   Bayón, Carmen ^b   Iglesias, Pedro ^b  

^a HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^b HOSPITAL GENERAL DE SEGOVIA   (Spain)

^c NONE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHYROID AGENT; LEVOTHYROXINE; LIOTHYRONINE; PROPYLTHIOURACIL; PROTEIN P55; RADIOACTIVE IODINE; THIAMAZOLE; THYROTROPIN; THYROXINE; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA RECEPTOR;

ADULT; ARTICLE; AUTOIMMUNE DISEASE; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG EFFECT; ENZYME IMMUNOASSAY; FEMALE; FREE LIOTHYRONINE INDEX; FREE THYROXINE INDEX; HUMAN; HYPERTHYROIDISM; HYPOTHYROIDISM; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; QUANTITATIVE ANALYSIS; THYROID FOLLICLE CELL; THYROID FUNCTION TEST; THYROIDECTOMY; TREATMENT OUTCOME; WEIGHT REDUCTION;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERTHYROIDISM; HYPOTHYROIDISM; MALE; MIDDLE AGED; RECEPTORS, TUMOR NECROSIS FACTOR; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; REGRESSION ANALYSIS; THYROID GLAND; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0036403024     PISSN: 03000664     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2265.2002.01629.x     Document Type: Article

References (31)

1. Aderka, D., Sorkine, P., Abu-Abid, S., Lev, D., Setton, A., Cope, A.P., Wallach, D. & Klausner, J. (1998) Shedding kinetics of soluble tumor necrosis factor (TNF) receptors after systemic TNF leaking during isolated limb perfusion: relevance to the pathophysiology of septic shock. Journal of Clinical Investigation, 101, 650-659.
2. Ajjan, R.A., Watson, P.F. & Weetman, A.P. (1996) Cytokines and thyroid function. Advances in Neuroimmunology, 6, 359-386.
3. Al-Humaidi, M.A. (2000) Serum cytokines levels in Graves' disease. Saudi Medical Journal, 21, 639-644.
4. Aust, G., Heuer, M., Laue, S., Lehmann, I., Hofmann, A., Heldin, N.E. & Scherbaum, W.A. (1996) Expression of tumour necrosis factor-alpha (TNF-α) mRNA and protein in pathological thyroid tissue and carcinoma cell lines. Clinical and Experimental Immunology, 105, 148-154.
5. Bartalena, L., Bogazzi, F., Brogioni, S., Grasso, L. & Martino, E. (1998) Role of cytokines in the pathogenesis of the euthyroid sick syndrome. European Journal of Endocrinology, 138, 603-614.
6. Bartalena, L., Brogioni, S., Grasso, L. & Martino, E. (1993) Increased serum interleukin-6 concentrations in patients with subacute thyroiditis: relationship with concomitant changes in serum T4-binding globulin concentrations. Journal of Endocrinological Investigation, 16, 213-218.
7. Bartalena, L., Grasso, L., Brogioni, S., Aghini-Lombardi, F., Braverman, L.E. & Martino, E. (1994) Serum interleukin-6 in amiodarone-induced thyrotoxicosis. Journal of Clinical Endocrinology and Metabolism, 78, 423-427.
8. Bossowski, A. & Urban, M. (2001) Serum levels of cytokines in children and adolescents with Graves' disease and non-toxic nodular goiter. Journal of Pediatric Endocrinology and Metabolism, 14, 741-747.
9. Buscema, M., Todd, I., Deuss, U., Hammond, L., Mirakian, R., Pujol-Borrell, R. & Bottazzo, G.F. (1989) Influence of tumor necrosis factor-α on the modulation by interferon-γ of HLA class II molecules in human thyroid cells and its effect on interferon-γ binding. Journal of Clinical Endocrinology and Metabolism, 69, 433-439.
10. Çelik, I., Akalin, S. & Erbas, T. (1995) Serum levels of interleukin 6 and tumor necrosis factor-α in hyperthyroid patients before and after propylthiouracil treatment. European Journal of Endocrinology, 132, 668-672.
11. Chopra, I.J., Sakane, S., Chua Teco, G. & N. (1991) A study of the serum concentration of tumor necrosis factor-α in thyroidal and nonthyroidal illnesses. Journal of Clinical Endocrinology and Metabolism, 72, 1113-1116.
12. Denz, H., Orth, B., Weiss, G., Gallati, H., Herrmann, R., Huber, P., Wachter, H. & Fuchs, D. (1993) Serum soluble tumour necrosis factor receptor 55 is increased in patients with haematological neoplasias and is associated with immune activation and weight loss. European Journal of Cancer, 29A, 2232-2235.
13. Drugarin, D., Negru, S., Koreck, A., Zosin, I. & Cristea, C. (2000) The pattern of a Th1 cytokine in autoimmune thyroiditis. Immunology Letters, 71, 73-77.
14. Heinrich, P.C., Castell, J.V. & Andus, T. (1990) Interleukin-6 and the acute phase response. Biochemical Journal, 265, 621-636.
15. Heney, D. & Whicher, J.T. (1995) Factors affecting the measurement of cytokines in biological fluids: implications for their clinical measurement. Annals of Clinical Biochemistry, 32, 358-368.
16. Komorowski, J., Jankiewicz, J., Robak, T., Blasinska-Morawiec, M. & Stepien, H. (1998) Cytokine serum levels as the markers of thyroid activation in Graves' disease. Immunology Letters, 60, 143-148.
17. Lantz, M., Malik, S., Slevin, M.L. & Olsson, I. (1990) Infusion of tumor necrosis factor (TNF) causes an increase in circulating TNF-binding protein in humans. Cytokine, 2, 402-406.
18. Old, L.J. (1985) Tumor necrosis factor (TNF). Science, 230, 630-633.
19. Ongphiphadhanakul, B., Fang, S.L., Tang, K.T., Patwardhan, N.A. & Braverman, L.E. (1994) Tumor necrosis factor-α decreases thyrotropin-induced 5′-deiodinase activity in FRTL-5 thyroid cells. European Journal of Endocrinology, 130, 502-507.
20. Pang, X.P., Hershman, J.M., Chung, M. & Eugene, A. (1989) Characterization of tumor necrosis factor-α receptors in human and rat thyroid cells and regulation of the receptors by thyrotropin. Endocrinology, 125, 1783-1788.
21. Pang, X.P., Yoshimura, M. & Hershman, J.M. (1993) Suppression of rat thyrotroph and thyroid cell function by tumor necrosis factor-α. Thyroid, 3, 325-330.
22. Salvi, M., Girasole, G., Pedrazzoni, M., Passeri, M., Giuliani, N., Minelli, R., Braverman, L.E. & Roti, E. (1996) Increased serum concentrations of interleukin-6 (IL-6) and soluble IL-6 receptor in patients with Graves' disease. Journal of Clinical Endocrinology and Metabolism, 81, 2976-2979.
23. Salvi, M., Pedrazzoni, M., Girasole, G., Giuliani, N., Minelli, R., Wall, J.R. & Roti, E. (2000) Serum concentrations of proinflammatory cytokines in Graves' disease: effect of treatment, thyroid function, ophthalmopathy and cigarette smoking. European Journal of Endocrinology, 143, 197-202.
24. Siddiqi, A., Monson, J.P., Wood, D.F., Besser, G.M. & Burrin, M. (1999) Serum cytokines in thyrotoxicosis. Journal of Clinical Endocrinology and Metabolism, 84, 435-439.
25. Tandon, N., Yan, S.L., Morgan, B.P. & Weetman, A.P. (1994) Expression and function of multiple regulators of complement activation in autoimmune thyroid disease. Immunology, 81, 643-647.
26. Turnbull, A.V. & Rivier, C.R. (1996) Cytokines within the neuroendocrine system. Current Opinion in Endocrinology and Diabetes, 3, 149-156.
27. Wakelkamp, I.M.M.J., Gerding, M.N., Van der Meer, C., Prummel, M.F. & Wiersinga, W.M. (2000) Both Th1- and Th2-derived cytokines in serum are elevated in Graves' ophthalmopathy. Clinical and Experimental Immunology, 121, 453-457.
28. Watson, P.F., Pickerill, A.P., Davies, R. & Weetman, A.P. (1994) Analysis of cytokine gene expression in Graves' disease and multinodular goiter. Journal of Clinical Endocrinology and Metabolism, 79, 355-360.
29. Weetman, A.P. (2000) Graves' disease. New England Journal of Medicine, 343, 1236-1248.
30. Weetman, A.P., Tandon, N. & Morgan, B.P. (1992) Antithyroid drugs and release of inflammatory mediators by complement-attacked thyroid cells. Lancet, 340, 633-666.
31. Zheng, R.Q., Abney, E.R., Chu, C.Q., Field, M., Maini, R.N., Lamb, J.R. & Feldmann, M. (1992) Detection of in vivo production of tumour necrosis factor-alpha by human thyroid epithelial cells. Immunology, 75, 456-462.